非酒精性脂肪性肝病患者的肝脏胰岛素抵抗并非通路选择性
研究纳入符合减重手术标准的肥胖患者,比较伴或不伴非酒精性脂肪性肝病(NAFLD)者的肝脏胰岛素抵抗。通过高胰岛素-正葡萄糖钳夹、氘水法和肝活检发现,NAFLD患者葡萄糖生成抑制受损且脂合成未见增加,肝细胞胰岛素信号从受体起即呈近端阻滞,提示脂合成增加或源于底物可利用性而非选择性胰岛素抵抗。
要点
- NAFLD患者胰岛素介导的葡萄糖生成抑制受损,但脂合成并未因胰岛素作用而增加。
- 肝细胞胰岛素信号在NAFLD中呈近端阻滞,同时影响葡萄糖和脂合成通路。
- NAFLD中脂合成增加可能由底物可利用性驱动,而非通路选择性胰岛素抵抗。
核心结论
- 人类NAFLD中急性脂合成增加不能由脂合成胰岛素作用的矛盾性增加解释,底物可利用性增加可能是关键。
研究设计与样本
- 研究纳入符合减重手术标准的肥胖受试者,伴NAFLD者16例,不伴NAFLD者15例。
- 采用高胰岛素-正葡萄糖钳夹结合[6,6-2H2]葡萄糖评估肝脏及外周葡萄糖代谢的胰岛素调节。
- 采用氘水(2H2O)评估空腹及碳水化合物驱动的肝脏新生脂肪生成(DNL)。
- 收集减重手术中肝活检样本评估肝细胞胰岛素信号。
主要发现
- 与不伴NAFLD者相比,NAFLD患者胰岛素介导的葡萄糖生成抑制受损。
- NAFLD患者葡萄糖刺激/高胰岛素条件下的脂合成减弱而非增加。
- 果糖刺激/低胰岛素条件下的脂合成在NAFLD中保持完整。
- 肝细胞胰岛素信号在胰岛素抵抗者中呈近端阻滞,从胰岛素受体水平起葡萄糖和脂合成通路信号均减弱。
- NAFLD患者中碳水化合物调节的脂合成转录因子ChREBP增加。
临床怎么用
- 临床评估NAFLD相关胰岛素抵抗时需关注肝细胞胰岛素信号近端阻滞,而非仅针对脂合成通路。
- 改善脂合成底物可利用性可能成为NAFLD治疗干预的潜在方向。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Both glucose and triglyceride production are increased in type 2 diabetes and nonalcoholic fatty liver disease (NAFLD). For decades, the leading hypothesis to explain these paradoxical observations has been selective hepatic insulin resistance wherein insulin drives de novo lipogenesis (DNL) while failing to suppress glucose production. Here, we aimed to test this hypothesis in humans. RESEARCH DESIGN AND METHODS: We recruited obese subjects who met criteria for bariatric surgery with (n = 16) or without (n = 15) NAFLD and assessed 1) insulin-mediated regulation of hepatic and peripheral glucose metabolism using hyperinsulinemic-euglycemic clamps with [6,6-2H2]glucose, 2) fasting and carbohydrate-driven hepatic DNL using deuterated water (2H2O), and 3) hepatocellular insulin signaling in liver biopsy samples collected during bariatric surgery. RESULTS: Compared with subjects without NAFLD, those with NAFLD demonstrated impaired insulin-mediated suppression of glucose production and attenuated-not increased-glucose-stimulated/high-insulin lipogenesis. Fructose-stimulated/low-insulin lipogenesis was intact. Hepatocellular insulin signaling, assessed for the first time in humans, exhibited a proximal block in insulin-resistant subjects: Signaling was attenuated from the level of the insulin receptor through both glucose and lipogenesis pathways. The carbohydrate-regulated lipogenic transcription factor ChREBP was increased in subjects with NAFLD. CONCLUSIONS: Acute increases in lipogenesis in humans with NAFLD are not explained by altered molecular regulation of lipogenesis through a paradoxical increase in lipogenic insulin action; rather, increases in lipogenic substrate availability may be the key.
引用
- Ter Horst KW, Vatner DF, Zhang D, et al. Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease. Diabetes Care. 2020. PMID: 33293347. doi:10.2337/dc20-1644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。